Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1124901

	registered interest
	date	07/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nusinersen
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza.
	tabling member printed	Baroness Thomas of Winchester
	uin	HL15576
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15577 question first answered 17/05/2019 11:07:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	3785 label Biography information for Baroness Thomas of Winchester

1124902

	registered interest
	date	07/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	National Institute for Health and Care Excellence
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March.
	tabling member printed	Baroness Thomas of Winchester
	uin	HL15577
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15576 question first answered 17/05/2019 11:07:46 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	3785 label Biography information for Baroness Thomas of Winchester

1125248

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ovarian Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) improve early diagnosis of ovarian cancer and (b) reduce the level of variation in diagnosis times between clinical commissioning groups.
	tabling member constituency	North East Derbyshire
	tabling member printed	Lee Rowley
	uin	252008
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>The NHS Cancer Programme is committed to improving early diagnosis as outlined in the Long Term Plan ambition to diagnose three-quarters of all cancers at stages 1 and 2 by 2028. This includes all stageable cancers.</p><p>To achieve this ambition, the NHS Cancer Programme is working on a number of programmes to improve early diagnosis rates for all cancers. The Rapid Diagnostic Centres (RDCs) are a new flagship policy in the Long Term Plan that offer patients a range of tests in the same day with rapid access to results. These RDCs starting to be rolled out in 2019/20 and will support the overall early diagnosis ambition. The RDCs will upgrade and bring together the latest diagnostic equipment and expertise, building on 10 models piloted with Cancer Research UK, which have focused on diagnosing cancers where patients often present with non-specific symptoms, often the case with ovarian cancer, and may go to their general practitioner many times before being sent for tests, such as blood and stomach cancers.</p><p> </p><p>A new cancer diagnosis standard, designed to ensure that patients find out within 28 days if they have cancer, will be introduced in 2020. All hospitals in England are now collecting data on how long it takes patients to reach cancer diagnosis, and they are working to improve performance over the next year and reduce unwarranted variation, for example geographical variation.</p><p> </p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 13:11:39 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4652 label Biography information for Lee Rowley

1125272

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Strokes: Death
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many deaths caused by stroke there were in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the number of deaths attributed to stroke in that period with the (a) expected average and (b) average over the last five years.
	tabling member constituency	Hammersmith
	tabling member printed	Andy Slaughter
	uin	251938
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>According to the Daily Air Quality Index there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for deaths caused by stroke in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 13:24:45 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1516 label Biography information for Andy Slaughter

1125273

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases: Death
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many deaths were caused by coronary heart disease in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the number of deaths attributed to heart disease in that period with the (a) expected average and (b) average over the last five years.
	tabling member constituency	Hammersmith
	tabling member printed	Andy Slaughter
	uin	251939
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>According to the Daily Air Quality Index, there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April 2019 and between 15 and 25 April 2019. The figures for deaths caused by coronary heart disease in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 13:22:33 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1516 label Biography information for Andy Slaughter

1125285

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Rural Areas
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department taking to enable the use of digital technology to increase access to healthcare for people in rural communities.
	tabling member constituency	North Cornwall
	tabling member printed	Scott Mann
	uin	252028
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>Digital technology is improving access to healthcare for rural communities:</p><p>- In April 2018, NHS Digital published a digital inclusion guide for health and social care aimed at local health and care organisations to help them to take practical steps to support digital inclusion in their communities, including those in rural areas who are more likely to be digitally excluded;</p><p> </p><p>- We are working closely with the Department for Digital, Culture, Media and Sport to ensure that health and care needs are taken into account in national digital infrastructure policy, are running two test beds under Department for Digital, Culture, Media and Sport’s 5G programme focused on improving access, and the 5G programme itself will address rural connectivity; and</p><p> </p><p>- The NHS App is now connected in over 52% of general practitioner (GP) practices. It provides a universal offer regardless of postcode. It gives patients a single safe and secure means to interact with their GP, including access to their GP record, make GP appointments, order repeat prescriptions, access 111 online for urgent medical questions. The improved NHS website has over 40 million visits a month.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 17/05/2019 13:15:13 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4496 label Biography information for Scott Mann

1125320

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Prescriptions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of asthma prescription charges on lifelong asthma sufferers.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	251955
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>The Department has made no such assessment.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 12:34:53 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1447 label Biography information for Andrew Rosindell

1125336

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to review which long-term health conditions should be exempt from NHS prescription charges.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	252045
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>The Department has no current plans to review or amend the list of medical conditions that provide exemption from prescription charges. Extensive arrangements are already in place to help people afford National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions.</p><p>To support those with greatest need who do not qualify for an exemption, prescription prepayment certificates are available. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 13:13:17 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4523 label Biography information for Catherine West

1125364

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ocrelizumab
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on the (a) negotiations for NHS access to and (b) appraisal of Ocrelizumab as a treatment for primary progressive MS.
	tabling member constituency	South Cambridgeshire
	tabling member printed	Heidi Allen
	uin	252055
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources.</p><p>NICE is currently developing technology appraisal guidance on the use of ocrelizumab for treating primary progressive multiple sclerosis, with final guidance expected in June 2019. NHS England and Roche have now reached a commercial agreement and on 9 May NICE published final draft guidance which recommended ocrelizumab within its marketing authorisation, as an option for treating early primary progressive multiple sclerosis with imaging features characteristic of inflammatory activity in adults. Ocrelizumab will now be routinely available for eligible adults.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 12:35:52 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4516 label Biography information for Heidi Allen

1125394

	registered interest
	date	08/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much money was accrued to the public purse under the pharmaceutical price regulation scheme and (b) what proportion of that money was allocated to clinical commissioning groups between 2014 and 2019.
	tabling member constituency	Rotherham
	tabling member printed	Sarah Champion
	uin	252068
	answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>Under the 2014 Pharmaceutical Price Regulation Scheme (PPRS), scheme members made payments to the Department. The 2014 PPRS has now delivered over £2.7 billion of PPRS payments. The following table shows the annual aggregate PPRS payments from 2014 until the end of the PPRS in December 2018. The 2019 Voluntary Scheme for Branded Medicines Pricing and Access is the current voluntary scheme.</p><table><tbody><tr><td><p>Period</p></td><td><p>Aggregate PPRS payments</p></td></tr><tr><td><p>2014</p></td><td><p>£311 million</p></td></tr><tr><td><p>2015</p></td><td><p>£847 million</p></td></tr><tr><td><p>2016</p></td><td><p>£628 million</p></td></tr><tr><td><p>2017</p></td><td><p>£387 million</p></td></tr><tr><td><p>2018</p></td><td><p>£615 million</p></td></tr></tbody></table><p> </p><p>Further aggregate net sales and payment information can be found at the following link:</p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information" target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p>Each year, the Department estimates the England share of expected income from the PPRS which is then included within NHS England baseline financial allocations. Decisions on how to allocate funding across the health system is for NHS England to determine, in line with patient need.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 12:39:55 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4267 label Biography information for Sarah Champion